Biogen – Pioneers In Neuroscience

You are here >>://Biogen – Pioneers In Neuroscience

Biogen – Pioneers In Neuroscience

BiogenBiogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases.

We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience. Our focus on Millions of people around the world are affected by multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Many people also suffer from less common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).

Biogen has some of the world’s best neurologists and neuroscientists. We engage with physicians and scientific leaders around the world with the aim to further medical research. Our focus on neuroscience, our deep scientific expertise and our courage to take risks make us leaders in the research and development of medicines to transform neuroscience to benefit society.

Disease Areas

Multiple Sclerosis
Biogen has pioneered the development of multiple sclerosis (MS) treatments for more than 25 years. We continue to innovate to advance MS treatment and improve outcomes for patients. Our research is focused on potentially transformative therapies, including the potential repair of the damage caused by MS. Our ongoing research into neurodegeneration and nerve repair will help pioneer new therapeutic solutions that may bring us closer to a cure for MS.

Spinal Muscular Atrophy
Previously, individuals with SMA and their families had no treatment options. This changed in December 2016 when Biogen received U.S. Food and Drug Administration (FDA) approval for the first and only therapy approved to treat SMA. The therapy has since been approved in the European Union, Japan, and other regions globally, and has helped thousands of patients around the world to date.

Alzheimer’s Disease
Our world-class neurology research and development organization is pushing towards novel approaches for previously intractable neurodegenerative conditions such as Alzheimer’s disease.We view Alzheimer’s disease as an area where we can make a tremendous difference in the lives of patients.

Biogen Product Portfolio

Below is a list of our company’s marketed products. This information is intended only for U.S. residents.

AVONEX® (interferon beta-1a)
BENEPALI® (etanercept)
FAMPYRA® (prolonged-release fampridine tablets)
FLIXABI® (infliximab)
IMRALDI™ (adalimumab)
PLEGRIDY® (peginterferon beta-1a)
SPINRAZA® (nusinersen)
TECFIDERA® (dimethyl fumarate)
TYSABRI® (natalizumab)
ZINBRYTA® (daclizumab)

Spinal Cord Injury

Spinal cord injury can result in paralysis of the muscles used for breathing; paralysis and/or loss of feeling in all or some of the trunk, arms, and legs; weakness; numbness; loss of bowel and bladder control; and numerous secondary conditions including respiratory problems, pressure sores, and sometimes fatal spikes in blood pressure. Approximately 12,000 new spinal cord injuries occur in the U.S. each year. A majority of injuries occur from motor vehicle accidents, falls, work-related accidents, sports injuries, and penetrations such as stab or gunshot wounds.

Our Membership Community

Our membership community provides a lifeline for many individuals that are focused on regaining their independence and improving their quality of life––whether they are leaving rehab after sustaining a spinal cord injury, learning to live with symptoms of a spinal cord disorder, or have spent years of frustration coping with disability. We provide members guidance and resources on a variety of topics they are passionate about, such as employment, affordable housing, transportation, health care, home- and community-based independent living, education, peer support, and leisure and recreation.
Donate to United Spinal today! spacer Join, membership is free spacer Sign up for our newsletter spacer Free Disability Publications from United Spinal spacer

Ask Us

United Spinal’s Ask Us program connects you with information, resources, and access to our “Ask Us Spinal Cord Central” help center. Browse the Knowledge Books below for answers to your questions. If you can’t find what you are looking for just Ask Us and one of our knowledgeable staff will provide you with answers.